Healthy Living Europe
SEE OTHER BRANDS

Keeping up with healthcare and wellness news from Europe

Healthy Living Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.

Press releases published on May 19, 2025

Lysosomal Storage Disorders Market Set to Expand Across the 7MM During the Forecast Period (2025–2034) with Advances in Enzyme Replacement Therapies | DelveInsight

Lysosomal Storage Disorders Market Set to Expand Across the 7MM During the Forecast Period (2025–2034) with Advances in Enzyme Replacement Therapies | DelveInsight

New York, USA, May 19, 2025 (GLOBE NEWSWIRE) -- Lysosomal Storage Disorders Market Set to Expand Across the 7MM During the Forecast Period (2025–2034) with Advances in Enzyme Replacement Therapies | DelveInsight The lysosomal storage disorders market is …

Early and Sustained Increase in Serum TTR Levels by Acoramidis Independently Predicted Improved Survival in the ATTRibute-CM Study

Early and Sustained Increase in Serum TTR Levels by Acoramidis Independently Predicted Improved Survival in the ATTRibute-CM Study

- For each 5-mg/dL increase in serum TTR level within 28 days of starting treatment, the relative risk reduction of mortality was up to 31.6% through Month 30, confirming the hypothesis that ever better levels of stabilization achieved by treatment with …

Global phase III trials demonstrate that nerandomilast slowed lung function decline in IPF and PPF, with similar discontinuation rates to placebo

Global phase III trials demonstrate that nerandomilast slowed lung function decline in IPF and PPF, with similar discontinuation rates to placebo

Boehringer Ingelheim announced today detailed findings from the Phase III FIBRONEER™-IPF and FIBRONEER™-ILD trials. These studies evaluated nerandomilast, an investigational oral, preferential inhibitor of phosphodiesterase 4B (PDE4B), in patients with …

Kymera Therapeutics Presents New Preclinical Data for KT-621, a First-In-Class, Oral STAT6 Degrader at the American Thoracic Society International Conference

Kymera Therapeutics Presents New Preclinical Data for KT-621, a First-In-Class, Oral STAT6 Degrader at the American Thoracic Society International Conference

KT-621, a potent, selective, oral STAT6 degrader, demonstrated comparable or superior activity to dupilumab in a newly disclosed preclinical chronic asthma model reversing disease progression KT-621 Phase 1 healthy volunteer SAD/MAD trial completed with …

The Coalition to Transform Clinical Trial Engagement Launches National “Champions for Change – PTO Initiative” to Expand Access to Clinical Trials for Working Patients with 7 Corporate and Non-Profit Members

The Coalition to Transform Clinical Trial Engagement Launches National “Champions for Change – PTO Initiative” to Expand Access to Clinical Trials for Working Patients with 7 Corporate and Non-Profit Members

CHICAGO, May 19, 2025 (GLOBE NEWSWIRE) -- In recognition of Clinical Trials Day, the Coalition to Transform Clinical Trial Engagement (CTCTE) proudly announces the launch of the Champions for Change – Paid Time Off (PTO) Initiative, a national effort to …

NovelMed’s Phase II Data in Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients: Ruxoprubart Shows Best-in-Class Efficacy as Monotherapy

NovelMed’s Phase II Data in Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients: Ruxoprubart Shows Best-in-Class Efficacy as Monotherapy

--- Ruxoprubart (NM8074) met all clinical endpoints, offering a safe, differentiated treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH). Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare hematological (Blood) disorder. Regulatory approval for the …

PhotoniCare's OtoSight Demonstrates More Accurate Diagnosis and a 50 Percent Reduction in Antibiotic Usage for Pediatric Ear Infections in Large Randomized Controlled Trial

PhotoniCare's OtoSight Demonstrates More Accurate Diagnosis and a 50 Percent Reduction in Antibiotic Usage for Pediatric Ear Infections in Large Randomized Controlled Trial

DURHAM, N.C. and GRAND RAPIDS, Mich., May 19, 2025 (GLOBE NEWSWIRE) -- PhotoniCare Inc., a medical device company dedicated to delivering innovation to frontline care that demonstrably enhances patient outcomes, is pleased to announce its progress in the …

Emergency Response and the Blood Supply

Emergency Response and the Blood Supply

Davenport, Iowa, May 19, 2025 (GLOBE NEWSWIRE) -- This week, ImpactLife joins emergency medical services providers across our region in celebrating May 18-24 as Emergency Medical Services Week. The EMS Week campaign honors the accomplishments of Emergency …

The Developing Doctor Launches New Online Course to Empower Early-Career Physicians

The Developing Doctor Launches New Online Course to Empower Early-Career Physicians

Iowa City, Iowa , May 19, 2025 (GLOBE NEWSWIRE) -- The Developing Doctor, a leader in physician coaching and education, is proud to announce the launch of its latest online course, "Mastery and Wellness: How to Thrive As a Physician." This innovative …

BeeCure Celebrates World Bee Day

BeeCure Celebrates World Bee Day

Poinciana, Fl , May 19, 2025 (GLOBE NEWSWIRE) -- As World Bee Day approaches on May 20th, BeeCure© proudly joins the global community in honoring the vital role bees play in sustaining our planet. This day not only highlights the significance of …

Healthcare Consulting & Contracting (HC3) Founder and Senior Toxicologist Dr. J. David Krause Honored with AIHA’s 2024 Lila Albin Best IEQ Paper Award

Healthcare Consulting & Contracting (HC3) Founder and Senior Toxicologist Dr. J. David Krause Honored with AIHA’s 2024 Lila Albin Best IEQ Paper Award

Tallahassee, Florida , May 19, 2025 (GLOBE NEWSWIRE) -- Healthcare Consulting …

Dr. Yesmean Wahdan from Bayer Discusses Women’s Health Month with YourUpdateTV

Dr. Yesmean Wahdan from Bayer Discusses Women’s Health Month with YourUpdateTV

NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- May marks Women’s Health Month, a timely reminder that while many women prioritize the health of others, their own well-being matters just as much. Recently, Dr. Yesmean Wahdan, Board-Certified OB/GYN and Medical …

BiomX CEO Jonathan Solomon to Present at Biomed Israel 2025 Conference

BiomX CEO Jonathan Solomon to Present at Biomed Israel 2025 Conference

NESS ZIONA, Israel, May 19, 2025 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that …

Milestone Scientific Appoints Highly Accomplished MedTech Executive Shanth Thiyagalingam to Board of Directors

Milestone Scientific Appoints Highly Accomplished MedTech Executive Shanth Thiyagalingam to Board of Directors

ROSELAND, N.J., May 19, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that Shanth Thiyagalingam, BMedSc, MMKTG, …

American Kidney Fund’s Kidney Health for All™ Health Equity Media Campaign Expands to More Communities Nationwide

American Kidney Fund’s Kidney Health for All™ Health Equity Media Campaign Expands to More Communities Nationwide

ROCKVILLE, Md., May 19, 2025 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) has launched the next phase of its national Kidney Health for All™ media campaign, connecting millions more people with resources to help prevent kidney disease in high-risk …

Nika Pharmaceuticals, Inc. (NIKA) Markets Analysis and €8.5 Billion Projected Revenue

Nika Pharmaceuticals, Inc. (NIKA) Markets Analysis and €8.5 Billion Projected Revenue

HENDERSON, Nev., May 19, 2025 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: NIKA) presents projected revenue for each market with exclusive distribution agreement. NIKA has previously reported an estimated potential €7.9 billion in revenue from …

Hospice Choices: VITAS® Healthcare Is Now Serving Marion County, Florida

Hospice Choices: VITAS® Healthcare Is Now Serving Marion County, Florida

OCALA, Fla., May 19, 2025 (GLOBE NEWSWIRE) -- Residents of North Central Florida now have easier access to high-quality, compassionate hospice services from the nation’s leading provider of end-of-life care. On May 15, VITAS Healthcare began accepting …

Zealand Pharma continues to strengthen strategic leadership of innovation in obesity and related conditions with appointment of Steven Johnson as Chief Development Officer

Zealand Pharma continues to strengthen strategic leadership of innovation in obesity and related conditions with appointment of Steven Johnson as Chief Development Officer

Press release – No. 9 / 2025 Zealand Pharma continues to strengthen strategic leadership of innovation in obesity and related conditions with appointment of Steven Johnson as Chief Development Officer Steven will lead the regulatory and development …

Porch Light Health Partners with CHESS Health to Offer a Contingency Management Incentives Program to Boost SUD Treatment Outcomes 

Porch Light Health Partners with CHESS Health to Offer a Contingency Management Incentives Program to Boost SUD Treatment Outcomes 

DENVER, May 19, 2025 (GLOBE NEWSWIRE) -- Porch Light Health (PLH) has partnered with CHESS Health to use its innovative, automated Contingency Management Rewards Engine in the treatment of individuals with substance use disorder (SUD) across thirteen of …

vTv Therapeutics Appoints Michael Tung, M.D., MBA, to Chief Financial Officer as Company Reinitiates Phase 3 Trial of Oral T1D Adjunctive Therapy to Insulin

vTv Therapeutics Appoints Michael Tung, M.D., MBA, to Chief Financial Officer as Company Reinitiates Phase 3 Trial of Oral T1D Adjunctive Therapy to Insulin

HIGH POINT, N.C., May 19, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company, today announced the appointment of Michael Tung, M.D., MBA as Executive Vice President and Chief Financial Officer, effective …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service